Zobrazeno 1 - 10
of 14
pro vyhledávání: '"Godfrey Andrew Aydon"'
Autor:
John M. Woodley, Ravendra Singh, Godfrey Andrew Aydon, Björn Gregertsen, Krist V. Gernaey, Frans L. Muller, Rafiqul Gani
Publikováno v:
Computers & Chemical Engineering
The discovery of an effective and safe pharmaceutical product is based on success in clinical trials. Often, several candidate compounds targeting the same disease area are tested in order to identify the most efficacious products. This involves the
Publikováno v:
Tetrahedron Letters. 52:2024-2027
The facile synthesis of a range of novel isoquinuclidinones from 6-acyl-cyclohex-2-enones is described, employing aqueous ammonia in a one-pot procedure involving initial conjugate addition of ammonia followed by cyclisation via intramolecular imine
Autor:
Jeffrey J Barlow, Lynn Scarlett, Keith Hopkinson Gibson, Susan Ashton, Walter Grundy, Lianne Henthorn, Laura Richards, Brenda Curry, Mark P Healy, Barker Andrew John, J. R. Woodburn, Godfrey Andrew Aydon
Publikováno v:
Bioorganic & Medicinal Chemistry Letters. 11:1911-1914
This paper describes the development of the epidermal growth factor receptor tyrosine kinase inhibitor ZD1839 from a lead series of 4-anilinoquinazoline compounds. ZD1839 has suitable properties for use as a clinically effective drug and shows activi
Autor:
L. Scarlett, Walter Grundy, Barker Andrew John, Keith Hopkinson Gibson, J. R. Woodburn, Susan Ashton, Godfrey Andrew Aydon, D. S. Brown, Brenda Curry
Publikováno v:
Bioorganic & Medicinal Chemistry Letters. 7:2723-2728
Investigation of structure-activity relationships of novel quinazolines has identified a 4-(4-iso-quinolylamino)-quinazoline and a 4-(trans-2-phenylcyclopropylamino)-quinazoline as potent inhibitors of EGF-receptor tyrosine kinase in vitro. Further m
Autor:
Bolin Geng, Joseph V. Newman, David E. Ehmann, John Breen, Patrick J. Brassil, Paul J. Ciaccio, Janelle Comita-Prevoir, Kosalaram Goteti, Herbert Barthlow, Mark T. D. Cronin, John McNulty, Stewart L. Fisher, Folkert Reck, Godfrey Andrew Aydon, Richard A. Alm
Publikováno v:
Journal of medicinal chemistry. 55(15)
Novel non-fluoroquinolone inhibitors of bacterial type II topoisomerases (DNA gyrase and topoisomerase IV) are of interest for the development of new antibacterial agents that are not impacted by target-mediated cross-resistance with fluoroquinolones
Publikováno v:
ChemInform. 43
A variety of partially reduced heterocycles is easily prepared by cyclization of alkynyl acetals in formic acid.
Publikováno v:
ChemInform. 42
The sequence converts 6-acyl-cyclohex-2-enones of type (I) directly to the required isoquinuclidinones.
Publikováno v:
ChemInform. 42
Autor:
Godfrey Andrew Aydon, Susan Ashton, J. R. Woodburn, Walter Grundy, L. Scarlett, Barker Andrew John, Brenda Curry, Keith Hopkinson Gibson, D. S. Brown
Publikováno v:
ChemInform. 29
Publikováno v:
HETEROCYCLES. 84:1013